Olivo Sciences
Olivo Sciences provides an agentic AI platform that unifies neuroscience data—including EHRs, imaging, multi-omics, and wearables—into a single patient view. The platform supports precision trial design, patient matching, commercialization, and real-world evidence generation for life sciences teams and clinicians. Its domain-trained AI models process de-identified, HIPAA-compliant data to link patient phenotypes to underlying biological mechanisms.
- Artificial Intelligence
- Healthcare Technology
- AI Agents
- Digital Health
- Data & Analytics
- Software Only
- Drug Discovery & Therapeutics
Funding
Funding not disclosed
across 1 round
Founders
Founder details are not available yet.
Product
Problem
Neuroscience drug development and clinical care are hindered by fragmented multimodal data, including EHRs, imaging, genomics, and wearable sensor streams, which are difficult to integrate and interpret. This complexity delays trial design, impedes identification of patients most likely to respond to therapies, and limits post-launch evidence generation for precision treatments.
Solution
Olivo offers a purpose-built agentic AI platform that connects diverse neuroscience data—clinical records, imaging, multi-omics, and wearables—into a unified view of each patient. The platform applies domain-trained AI to support protocol design, predict therapeutic response, match patients to clinical trials across a site network, and inform commercialization strategies. It also tracks real-world response at scale for safety monitoring and lifecycle management. By linking patient phenotypes to underlying biological mechanisms, Olivo enables more precise trial enrollment and ensures therapies reach the right patients from first protocol draft through post-launch evidence.
Target Audience
Primary customers are life sciences teams—including biopharma companies and clinical research organizations—working on neuroscience programs, as well as clinicians involved in precision trial design, patient matching, and care.
Features
- Agentic AI platform purpose-built for neuroscience, integrating EHR, notes, labs, MRI, PET, CT, genomic, proteomic, gait, sleep, and tremor data
- Predictive modeling for protocol and endpoint design, testing inclusion/exclusion criteria against real-world data before enrollment
- AI-driven patient matching across a clinical site network, identifying patients most likely to respond to specific study criteria
- Commercialization analytics that predict patient benefit to target precision therapies at launch
- Real-world evidence generation for post-launch safety monitoring and lifecycle strategy refinement
- De-identified, HIPAA-compliant data processing with domain-trained neuroscience AI models